These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3416552)

  • 21. Effects of food on oxaprozin bioavailability.
    Chiang ST; Knowles JA; Hubsher JA; Ruelius HW; Walker BR
    J Clin Pharmacol; 1984; 24(8-9):381-5. PubMed ID: 6480879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative irritancy of oxaprozin on the gastrointestinal tract of rats and mice: relationship to drug uptake and effects in vivo on eicosanoid metabolism.
    Rainsford KD
    Aliment Pharmacol Ther; 1988 Oct; 2(5):439-50. PubMed ID: 2979266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactions of oxaprozin-1-O-acyl glucuronide in solutions of human plasma and albumin.
    Ruelius HW; Kirkman SK; Young EM; Janssen FW
    Adv Exp Med Biol; 1986; 197():431-41. PubMed ID: 3766273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Panic disorder in a patient taking oxaprozin.
    Hough DW; Sellers R; Cantilena LR
    Am J Psychiatry; 1995 Jan; 152(1):149. PubMed ID: 7802107
    [No Abstract]   [Full Text] [Related]  

  • 25. Benoxaprofen kinetics in renal impairment.
    Aronoff GR; Ozawa T; DeSante KA; Nash JF; Ridolfo AS
    Clin Pharmacol Ther; 1982 Aug; 32(2):190-4. PubMed ID: 7094505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxaprozin prodrug as safer nonsteroidal anti-inflammatory drug: Synthesis and pharmacological evaluation.
    Peesa JP; Atmakuri LR; Yalavarthi PR; Mandava Venkata BR; Rasheed A; Pachava V
    Arch Pharm (Weinheim); 2018 Feb; 351(2):. PubMed ID: 29283449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of oxaprozin.
    Hale VG; Bashaw ED
    Clin Pharm; 1993 Apr; 12(4):255-6. PubMed ID: 8458176
    [No Abstract]   [Full Text] [Related]  

  • 28. Interactions between oxaprozin glucuronide and human serum albumin.
    Wells DS; Janssen FW; Ruelius HW
    Xenobiotica; 1987 Dec; 17(12):1437-49. PubMed ID: 3439193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxaprozin: a once-daily nonsteroidal anti-inflammatory drug.
    Miller LG
    Clin Pharm; 1992 Jul; 11(7):591-603. PubMed ID: 1617910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of alfentanil in chronic renal failure.
    Chauvin M; Lebrault C; Levron JC; Duvaldestin P
    Anesth Analg; 1987 Jan; 66(1):53-6. PubMed ID: 3099599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of cefadroxil in normal subjects and in patients with renal insufficiency.
    Humbert G; Leroy A; Fillastre JP; Godin M
    Chemotherapy; 1979; 25(4):189-95. PubMed ID: 456077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assay interaction between oxaprozin and phenytoin.
    Patel T; Radomski KM; Chandler MH
    Ann Pharmacother; 1997 Feb; 31(2):254. PubMed ID: 9034434
    [No Abstract]   [Full Text] [Related]  

  • 33. Bromfenac disposition in patients with impaired kidney function.
    Ermer JC; Boni JP; Cevallos WH; DeCleene S; Burghart P; Rudnick MR; Fruncillo RJ; Berns JS; Cohen RM
    Clin Pharmacol Ther; 1997 Mar; 61(3):312-8. PubMed ID: 9084456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of tiaprofenic acid in children after a single oral dose.
    Bertin L; Rey E; Pons G; Mathiot JL; Richard MO; Chrétien P; Saint-Maurice C; Moran C; Ginisty D; Olive G
    Eur J Clin Pharmacol; 1991; 41(3):251-3. PubMed ID: 1748142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of hemodialysis on plasma kinetics of fenofibrate in chronic renal failure.
    Desager JP; Costermans J; Verberckmoes R; Harvengt C
    Nephron; 1982; 31(1):51-4. PubMed ID: 7110477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis.
    Don BR; Spin G; Nestorov I; Hutmacher M; Rose A; Kaysen GA
    J Pharm Pharmacol; 2005 Nov; 57(11):1407-13. PubMed ID: 16259772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of intravenous pentamidine in patients with normal renal function or receiving hemodialysis.
    Conte JE
    J Infect Dis; 1991 Jan; 163(1):169-75. PubMed ID: 1984463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
    Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE
    Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anti-inflammatory activity of a non-steroidal anti-inflammatory agent, oxaprozin, in experimental models].
    Higuchi S; Osada Y; Shioiri Y; Nakaike S; Muramatsu M; Tanaka M; Arai I; Amanuma F; Otomo S; Aihara H
    Nihon Yakurigaku Zasshi; 1984 May; 83(5):383-94. PubMed ID: 6432656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.